Chemosensitization by erythropoietin through inhibition of the NF-κB rescue pathway

Oncogene

Volumn 24, Issue 5, 2005, Pages 737-745

  Carvalho, Gabrielle ^a   Lefaucheur, Carmen ^a   Cherbonnier, Claire ^a   Métivier, Didier ^b   Chapel, Alain ^c   Pallardy, Marc ^a   Bourgeade, Marie Françoise ^a   Charpentier, Bernard ^a   Hirsch, François ^a   Kroemer, Guido ^b  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

Apoptosis; Jak; Leukemia; Renal carcinoma

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; DAUNORUBICIN; ERYTHROPOIETIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BAK; PROTEIN BAX; PROTEIN P50; PROTEIN P53; RECOMBINANT ERYTHROPOIETIN; VINBLASTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, RENAL CELL; CELL DEATH; CELL LINE, TUMOR; DAUNORUBICIN; ERYTHROPOIETIN; HUMANS; JANUS KINASE 2; KIDNEY NEOPLASMS; NF-KAPPA B; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; U937 CELLS; VINBLASTINE;

EID: 13444253909     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208205     Document Type: Article

References (53)

1. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K and Verma A. (2001). Cancer Res., 61, 3561-3565.
2. Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD and Bennett CL. (2004). Am. J. Med, 116, 28-34.
3. Angevin E, Glukhova L, Pavon C, Chassevent A, Terrier-Lacombe MJ, Goguel AF, Bougaran J, Ardouin P, Court BH, Perrin JL, Vallancien G, Triebel F and Escudier B. (1999). Lab. Invest., 79, 879-888.
4. Baldwin Jr AS. (1996). Annu. Rev. Immunol, 14, 649-683.
5. Bazan JF. (1990). Immunol. Today, 11, 350-354.
6. Besancon F, Atfi A, Gespach C, Cayre YE and Bourgeade MF. (1998). Proc. Natl. Acad. Sci. USA, 95, 8081-8086.
7. Bunworasate U, Arnouk H, Minderman H, O'Loughlin KL, Sait SN, Barcos M, Stewart CC and Baer MR. (2001). Blood, 98, 3492-3494.
8. Castedo M, Ferri K, Roumier T, Metivier D, Zamzami N and Kroemer G. (2002). J. Immunol. Methods, 265, 39-47.
9. Castedo M and Kroemer G. (2002). Trends Cell Biol., 12, 446-447.
10. Chapel A, Poncet P, Neildez-Nguyen TMA, Vétillard J, Brouard N, Goupy C, Chavanel G, Hirsch F and Thierry D. (1999). Exp. Hematol., 27, 250-258.
11. Cherbonnier C, Déas O, Carvalho G, Vassal G, Durrbach A, Haeffner A, Charpentier B, Benard J and Hirsch F. (2003). Br. J. Cancer, 89, 1108-1115.
12. Cherbonnier C, Déas O, Vassal G, Merlin J-L, Haeffner A, Senik A, Charpentier B, Dürrbach A, Bénard J and Hirsch F. (2002). Cancer Gene. Ther., 9, 497-504.
13. Debatin KM, Poncet D and Kroemer G. (2002). Oncogene, 21, 8786-8803.
14. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R and Franzoso G. (2001). Nature, 414, 308-313.
15. Durrbach A, Angevin E, Poncet P, Rouleau M, Chavanel G, Chapel A, Thierry D, Gorter A, Hirsch R, Charpentier B, Senik A and Hirsch F. (1999). Cancer Gene Ther., 6, 564-571.
16. Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J and Boxer LM. (2004). Blood, 103, 1043-1049.
17. Ghezzi P and Brines M. (2004). Cell Death Differ., 11, S37-S44.
18. Gilmore TD. (1999). Oncogene, 22, 6842-6844.
19. Griffiths GJ, Dubrez L, Morgan CP, Jones NA, Whitehouse J, Corfe BM, Dive C and Hickman JA. (1999). J. Cell Biol., 144, 903-914.
20. Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin ASJ. (1999). Mol. Cell. Biol., 19, 5785-5799.
21. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
22. Hideshima T, Chauhan D, Hayashi T, Akiyama M, Mitsiades N, Mitsiades C, Podar K, Munshi NC, Richardson PG and Anderson KC. (2003). Oncogene, 22, 8386-8393.
23. Jolly C, Usson Y and Morimoto RI. (1999) 96, 6769-6774.
24. Kaltschmidt B, Kaltschmidt C, Hehner SP, Droge W and Schmitz ML. (1999). Oncogene, 18, 3213-3225.
25. Kane RC, Bross PF, Farrell AT and Pazdur R. (2003). Oncologist, 8, 508-513.
26. Karin M. (1999). Oncogene, 18, 6867-6874.
27. Karin M, Cao Y, Greten FR and Li ZW. (2002). Nat. Rev. Cancer, 2, 301-310.
28. Karin M and Lin A. (2002). Nat. Immunol., 3, 221-227.
29. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LA, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A and Brines M. (2004). Science, 305, 239-242.
30. Leyland-Jones B. (2003). Lancet Oncol., 4, 459-460.
31. Littlewood T and Mandelli F. (2002). Semin. Oncol., 29, 40-44.
32. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ and Kay MA. (2002). Nature, 418, 38-39.
33. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A and Roifman CM. (1996). Nature, 379, 645-648.
34. Minet E, Michel G, Remade J and Michiels C. (2000). Int. J. Mol. Med., 5, 253-259.
35. Mittelman M, Zeidman A, Kanter P, Katz O, Oster H, Rund D and Neumann D. (2004). Eur. J. Haematol., 72, 155-165.
36. Nechushtan A, Smith CL, Hsu YT and Youle RJ. (1999). EMBO J., 18, 2330-2341.
37. Oda A, Sawada K, Druker BJ, Ozaki K, Takano H, Koizumi K, Fukada Y, Handa M, Koike T and Ikeda Y. (1998). Blood, 92, 443-451.
38. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G and Ihle JN. (1998). Cell, 93, 385-395.
39. Perfettini J-L, Roumier T, Castedo M, Larochette N, Boya P, Reynal B, Lazar V, Ciccosanti F, Nardacci R, Penninger JM, Piacentini M and Kroemer G. (2004). J. Exp. Med., 199, 629-640.
40. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP and Anderson KC. (2003). N Engl. J. Med., 348, 2609-2617.
41. Schwartzberg L, Shiffman R, Tomita D, Stolshek B, Rossi G and Adamson R. (2003). Clin. Ther., 25, 2781-2796.
42. Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, Casanova JL and Israel A. (2002). Hum. Mol. Genet., 11, 2371-2375.
43. Takeshita A, Shinjo K, Naito K, Ohnishi K, Higuchi M and Ohno R. (2002). Leuk. Lymphoma, 43, 261-264.
44. Wang CY, Guttridge DC, Mayo MW and Baldwin Jr AS. (1999). Mol. Cell. Biol., 19, 5923-5929.
45. Wang CY, Mayo MW and Baldwin Jr AS. (1996). Science, 274, 784-787.
46. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS. (1998). Science, 281, 1680-1683.
47. Westenfelder C and Baranowski RL. (2000). Kidney Int., 58, 647-657.
48. Williams SA and McConkey DJ. (2003). Cancer Res., 63, 7338-7344.
49. Wu MX, Ao Z, Prasad KVS, Wu R and Schlossman SF. (1998). Science, 281, 998-1001.
50. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ and Israel A. (1998). Cell, 93, 1231-1240.
51. Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A, Onozaki M, Hashimoto M, Musha T, Ogawa K, Fujita H, Nakamura Y, Shiozaki H and Utsumi H. (2003). Carcinogenesis, 24, 1021-1029.
52. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and Kroemer G. (1995a). J. Exp. Med, 182, 367-377.
53. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssière J-L, Petit PX and Kroemer G. (1995b). J. Exp. Med, 181, 1661-1672.